Short Interest in Procaps Group S.A. (NASDAQ:PROC) Declines By 18.4%

Procaps Group S.A. (NASDAQ:PROC) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 133,300 shares, a drop of 18.4% from the December 15th total of 163,300 shares. Based on an average daily volume of 98,600 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.1% of the shares of the stock are sold short.

Procaps Group Stock Performance

Shares of Procaps Group stock traded down $0.04 during trading hours on Friday, reaching $1.71. The company’s stock had a trading volume of 19,922 shares, compared to its average volume of 35,161. The firm has a 50 day moving average price of $1.85 and a 200-day moving average price of $2.00. Procaps Group has a one year low of $0.50 and a one year high of $4.46.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.